Clinical trial

68Ga-PSMA-11 Patients With Newly Diagnosed and Recurrent Prostate Cancer (Firefly)

NCT04854369

Study summary

ClinicalTrials.gov

68Ga-PSMA-11 Patients With Newly Diagnosed and Recurrent Prostate Cancer (Firefly)

Design: EXPANDED_ACCESS · Status: NO LONGER AVAILABLE · Phase: Not specified

Loading study purpose, treatment groups and outcomes…

View the complete registry record, eligibility and contacts at ClinicalTrials.gov

Drugs and interventions used in this trial

1 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

DRUG · Unmapped registry intervention 68 Ga-PSMA-11 prepared using a PSMA-11 Sterile Cold Kit Find medicine records · Find other trials using this name

StatusNO_LONGER_AVAILABLE

Study typeEXPANDED_ACCESS

Start dateUnknown

PhaseN/A

Conditions

Prostatic Neoplasmsunresolved

Prostatic Neoplasms, Castration-Resistantunresolved

Interventions

68 Ga-PSMA-11 prepared using a PSMA-11 Sterile Cold KitDRUG

Sponsors & collaborators

Tulane Universitylead sponsor

Mapped research locations

New OrleansLouisiana, United States1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT04854369 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.